Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 1
2013 2
2015 1
2016 2
2017 2
2018 6
2019 6
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.
Schultz MJ, Holdbrooks AT, Chakraborty A, Grizzle WE, Landen CN, Buchsbaum DJ, Conner MG, Arend RC, Yoon KJ, Klug CA, Bullard DC, Kesterson RA, Oliver PG, O'Connor AK, Yoder BK, Bellis SL. Schultz MJ, et al. Among authors: Yoon KJ. Cancer Res. 2016 Jul 1;76(13):3978-88. doi: 10.1158/0008-5472.CAN-15-2834. Epub 2016 May 23. Cancer Res. 2016. PMID: 27216178 Free PMC article.
The role of ICAM-2 in neuroblastoma.
Yoon KJ, Miller AL, Kreitzburg KM. Yoon KJ, et al. Oncoscience. 2015 Nov 23;2(11):915-6. doi: 10.18632/oncoscience.273. eCollection 2015. Oncoscience. 2015. PMID: 26697524 Free PMC article. No abstract available.
Sphingolipid metabolism and drug resistance in ovarian cancer.
Kreitzburg KM, van Waardenburg RCAM, Yoon KJ. Kreitzburg KM, et al. Among authors: Yoon KJ. Cancer Drug Resist. 2018;1:181-197. doi: 10.20517/cdr.2018.06. Epub 2018 Sep 19. Cancer Drug Resist. 2018. PMID: 31891125 Free PMC article.
Dysregulated human Tyrosyl-DNA phosphodiesterase I acts as cellular toxin.
Cuya SM, Comeaux EQ, Wanzeck K, Yoon KJ, van Waardenburg RC. Cuya SM, et al. Among authors: Yoon KJ. Oncotarget. 2016 Dec 27;7(52):86660-86674. doi: 10.18632/oncotarget.13528. Oncotarget. 2016. PMID: 27893431 Free PMC article.
JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of Cholangiocarcinoma.
Garcia PL, Miller AL, Gamblin TL, Council LN, Christein JD, Arnoletti JP, Heslin MJ, Reddy S, Richardson JH, Cui X, van Waardenburg RCAM, Bradner JE, Yang ES, Yoon KJ. Garcia PL, et al. Among authors: Yoon KJ. Mol Cancer Ther. 2018 Jan;17(1):107-118. doi: 10.1158/1535-7163.MCT-16-0922. Epub 2017 Nov 15. Mol Cancer Ther. 2018. PMID: 29142067 Free PMC article.
Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma.
Stafman LL, Mruthyunjayappa S, Waters AM, Garner EF, Aye JM, Stewart JE, Yoon KJ, Whelan K, Mroczek-Musulman E, Beierle EA. Stafman LL, et al. Among authors: Yoon KJ. Oncotarget. 2018 Apr 27;9(32):22665-22679. doi: 10.18632/oncotarget.25205. eCollection 2018 Apr 27. Oncotarget. 2018. PMID: 29854306 Free PMC article.
FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer.
Kreitzburg KM, Fehling SC, Landen CN, Gamblin TL, Vance RB, Arend RC, Katre AA, Oliver PG, van Waardenburg RCAM, Alvarez RD, Yoon KJ. Kreitzburg KM, et al. Among authors: Yoon KJ. Cancer Lett. 2018 Nov 1;436:75-86. doi: 10.1016/j.canlet.2018.08.015. Epub 2018 Aug 16. Cancer Lett. 2018. PMID: 30120964 Free PMC article.
The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survival.
Stafman LL, Waldrop MG, Williams AP, Aye JM, Stewart JE, Mroczek-Musulman E, Yoon KJ, Whelan K, Beierle EA. Stafman LL, et al. Among authors: Yoon KJ. J Pediatr Surg. 2019 Jun;54(6):1206-1213. doi: 10.1016/j.jpedsurg.2019.02.029. Epub 2019 Feb 28. J Pediatr Surg. 2019. PMID: 30898394 Free PMC article.
22 results
Jump to page